← Return to Cytochrome P450 Drug Metabolization Polymorphisms

Discussion

Cytochrome P450 Drug Metabolization Polymorphisms

Just Want to Talk | Last Active: Jan 22, 2017 | Replies (25)

Comment receiving replies
@dawn_giacabazi

The main thing we focus on with our patients is drug toxicities that can be predicted by P450 polymorphism include those exerted by codeine, tramadol, warfarin, acenocoumarol, and clopidogrel. We also evaluate the patients smoking habits because the polymorphic CYP2A6 has a role in nicotine metabolism and smoking behavior.

Drug-drug interactions are of particular importance with respect to adverse effects. In fact, adverse drug reactions (ADRs) are one of the major causes of death, amounting to the fifth leading cause in the United States, encompassing 100,000 deaths annually. In addition, ADRs are also responsible for up to 7% of hospitalizations.

This is why we are working with our physicians to make pharmacogenetic testing become standard practice prior to prescribing and dosing medications.

Smiles
Dawn

Jump to this post


Replies to "The main thing we focus on with our patients is drug toxicities that can be predicted..."

YAY! I'm sure it will take a few years, but it's necessary. My Pharmacogenomics guy told me that they realize at Mayo that they need to educate their own doctors. Acknowledging this deficit is the first step, and I'm glad that such a powerful-yet-morally-sound organization is leading the way for the remainder of the country.

You'll find this interesting... when I got my results, I shared them with my brother, who lives in VA. About a week later, he shared a link from a local hospital there who is now including pharmacogenomic testing with all of their newborn screening. So cool!